Drugplain

HALLS Mentholyptus 6.4 mg/1

Menthol · LOZENGE · Mondelez Global LLC

No Recall History
Plain English

HALLS Mentholyptus is a lozenge containing menthol at 6.4 mg/1, taken oral. Manufactured by Mondelez Global LLC.

Key Facts

Brand Name
HALLS Mentholyptus
Generic Name
Menthol
NDC Code (Product)
12546-721
Manufacturer
Mondelez Global LLC
Strength
6.4 mg/1
Dosage Form
LOZENGE
Route
ORAL
Marketing Status
Application #
M012
Marketing Start
09/01/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

off label use92 reports
drug ineffective89 reports
dyspnoea85 reports
fatigue84 reports
pain76 reports
pruritus76 reports
cough68 reports
headache67 reports
dizziness65 reports
diarrhoea61 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses <temporarily relieves:> cough due to a cold occasional minor irritation or sore throat

Dosage & Administration

Directions adults and children 5 years and over: dissolve 1 drop slowly in the mouth. Repeat every 2 hours as needed. children under 5 years: ask a doctor

Warnings

Warnings < Sore throat warning : if sore throat is severe, persists for more than 2 days, is accompanied by fever, headache, rash, swelling, or vomiting, consult a doctor promptly. These may be serious.>

Frequently Asked Questions

What is HALLS Mentholyptus used for?

HALLS Mentholyptus contains Menthol. It is a lozenge taken oral. Consult your doctor for specific uses.

Is HALLS Mentholyptus a controlled substance?

HALLS Mentholyptus is not classified as a controlled substance by the DEA.

What is the generic name for HALLS Mentholyptus?

The generic name for HALLS Mentholyptus is Menthol. There are 12 other brand versions of Menthol.

What is the NDC code for HALLS Mentholyptus 6.4 mg/1?

The NDC (National Drug Code) for HALLS Mentholyptus 6.4 mg/1 is 12546-721, listed by Mondelez Global LLC.